US EditionPublished • loading... • Updated
Greenhaven Bets Over $143 Million on a Turnaround at Medical Devices Leader Baxter
Summary by The Motley Fool
2 Articles
2 Articles
In order to continue to release 30 to 40 new medical devices per year, the Stéphanois family company invests an average of 4% of its turnover in research and development.
·Paris, France
Read Full Article
Greenhaven Bets Over $143 Million on a Turnaround at Medical Devices Leader Baxter
Key PointsGreenhaven bought 6,288,349 shares for an estimated $143.19 million based on quarterly average pricing.Transaction equates to 2.77% of Greenhaven’s 13F reportable assets under management.Post-trade stake: 6,288,349 shares valued at $143.19 million.These 10 stocks could mint the next wave of millionaires › On Nov. 4, 2025, Greenhaven Associates disclosed a new position in Baxter International (NYSE:BAX), acquiring approximately 6,288,34…
·Alexandria, United States
Read Full ArticleCoverage Details
Total News Sources2
Leaning Left1Leaning Right1Center0Last UpdatedBias Distribution50% Left, 50% Right
Bias Distribution
- 50% of the sources lean Left, 50% of the sources lean Right
50% Right
L 50%
R 50%
Factuality
To view factuality data please Upgrade to Premium
